Reaction

Blood Parathyroid Hormone Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,472 reports · 92 co-occurring drugs

As of the last recalculation, Blood Parathyroid Hormone Decreased appears in 1,472 FAERS reports alongside 92 co-occurring drug terms. The strongest observed disproportionality signal is FEBUXOSTAT TABLETS 40 MG (PRR 221.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Febuxostat Tablets 40 Mg	144	221.8	225.0
Febuxostat Tablets 80 Mg	144	221.8	225.0
Dimenhydrinate	147	216.6	219.6
Sulfasalazine	593	178.8	180.2
Febuxostat	165	156.7	158.2
Alendronate Sodium	590	137.3	138.1
Tocilizumab	612	129.1	129.8
Leflunomide	576	127.2	127.9
Abatacept	595	101.3	101.7
Colchicine	157	94.2	94.8
Hydroxychloroquine Sulfate	426	92.6	93.1
Risedronate Sodium	158	80.4	80.8
Hydroxychloroquine	327	79.3	79.7
Tofacitinib Citrate	65	73.3	73.7
Ibuprofen And Diphenhydramine Citrate	110	72.1	72.5
Infliximab	612	67.1	67.3
Cinacalcet Hydrochloride	189	65.6	65.9
Golimumab	312	65.0	65.2
Rituximab	588	64.8	65.0
Iron Sucrose	42	64.1	64.4
Telmisartan	74	61.7	61.9
Adalimumab-Fkjp	163	55.8	56.0
Dexlansoprazole	147	55.3	55.4
Pramipexole	57	54.7	54.9
Adalimumab-Aaty	163	54.6	54.8
Alendronate Sodium Tablet	67	53.5	53.7
Tofacitinib	473	52.9	53.1
Adalimumab-Adaz	164	49.3	49.5
Doxyclycline Hyclate	55	47.4	47.6
Cyanocobalamin	101	46.5	46.6
Cyclosporine	280	43.7	43.8
Certolizumab Pegol	280	41.5	41.6
Esomeprazole Magnesium Capsule, Delayed Release	38	38.0	38.1
Esomeprazole Magnesium Delayed Release Capsules	38	38.0	38.1
Esomeprazole Magnesium Dihydrate	38	37.8	37.9
Magnesium Oxide	104	37.7	37.8
Azathioprine	190	34.9	34.9
Naproxen	171	34.7	34.8
Celecoxib	237	30.1	30.2
Methotrexate	562	29.9	30.0
Methotrexate Sodium	609	29.5	29.6
Budesonide	105	27.1	27.1
Prednisone	583	26.5	26.5
Diphenhydramine Hydrochloride Capsule, Liquid Filled	37	25.1	25.1
Ustekinumab	158	24.3	24.4
Iron	104	23.6	23.6
Etanercept	605	23.6	23.6
Paricalcitol	23	23.4	23.4
Propranolol Hydrochloride	109	23.0	23.0
Esomeprazole	89	21.5	21.6
Adalimumab	618	20.6	20.6
Bendamustine Hydrochloride	17	20.3	20.3
Naproxen Sodium	175	19.5	19.5
Apremilast	168	18.2	18.2
Calcitriol Capsules 0.25 Mcg	25	17.9	17.9
Calcitriol Capsules 0.5 Mcg	25	17.9	17.9
Teriparatide	130	17.8	17.8
Calcitriol	25	17.7	17.7
Bendamustine Hcl	18	16.6	16.6
Desoximetasone	22	16.6	16.6
Paroxetine Hydrochloride Hemihydrate	38	16.5	16.6
Folic Acid	243	16.3	16.3
Paroxetine	38	16.2	16.2
Doxycycline Hyclate	70	15.3	15.4
Ixekizumab	39	15.3	15.3
Doxycycline	70	15.2	15.2
Diphenhydramine Hydrochloride	148	13.9	13.9
Ramipril	110	13.5	13.5
Ibuprofen Capsule	164	13.0	13.0
Ibuprofen Tablet, Film Coated	164	13.0	13.0
Ibupfrofen	164	13.0	13.0
Ibuprofen Tablets Usp, 200Mg	164	13.0	13.0
Ibuprofen Oral	164	13.0	13.0
Ibuprofen Capsules 200 Mg	164	13.0	13.0
Ibuprofen 200 Mg	164	12.9	13.0
Ibuprofen 200Mg	164	12.9	13.0
Atenolol	112	12.8	12.8
Oxycodone	151	12.6	12.6
Secukinumab	130	12.4	12.4
Paroxetine Hydrochloride	72	11.7	11.7
Bupropion	36	11.7	11.7
Naproxen Sodium Tablet, Coated	11	11.6	11.6
Naproxen Sodium, Coated Tablets	11	11.6	11.6
Naproxen Sodium 220Mg	11	11.5	11.6
Epoetin Alfa	9	10.8	10.8
Anakinra	12	10.3	10.3
Abaloparatide	21	10.2	10.2
Asfotase Alfa	7	9.9	9.9
Morphine Sulfate	73	8.9	8.9
Oxycodone Hydrochloride	76	5.2	5.2
Bortezomib	32	5.1	5.2
Sevelamer Carbonate	4	4.9	4.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.